Latest News for: praxis

Edit

Rights issue of Equity Shares of PRAXIS HOME RETAIL LIMITED (BSE Ltd)

Public Technologies 17 Mar 2025
Subject Rights issue of Equity Shares of PRAXIS HOME RETAIL LIMITED ... Trading Members of the Exchange are hereby informed that PRAXIS HOME RETAIL LIMITED has fixed Record Date for the purpose of Rights Issue of Equity Shares of the Company.
Edit

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nasdaq Globe Newswire 04 Mar 2025
BOSTON, March 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc ... shares of its common stock to six new non-executive employees under the Praxis Precision Medicines, Inc.
Edit

Prospectus Certification by Investment Company (Form 497J) (Praxis Mutual Funds)

Public Technologies 04 Mar 2025
). PRAXIS FUNDS. 1110 N. MAIN STREET. GOSHEN, IN 46528. TEL. (800) 977-2947. March 4, 2025. VIA EDGAR SUBMISSION ... Praxis Funds ... 1 ... 2 ... Praxis Mutual Funds published this content on March 04, 2025, and is solely responsible for the information contained therein.
Edit

Praxis Precision Medicines Provides Update on Essential3 and Corporate Update (Form 8-K) (Praxis Precision Medicines Inc)

Public Technologies 28 Feb 2025
) Praxis Precision Medicines Provides Update on Essential3 and Corporate Update. BOSTON, February 28, 2025 (GLOBE NEWSWIRE) - Praxis Precision Medicines, Inc ... oIn December 2024, Praxis received Rare Pediatric Disease Designation (RPDD) from the U.S.
Edit

Initial Registration Statement for Employee Benefit Plan (Form S-8) (Praxis Precision Medicines Inc)

Public Technologies 28 Feb 2025
PRAXIS PRECISION MEDICINES, INC ... PRAXIS PRECISION MEDICINES, INC ... PRAXIS PRECISION MEDICINES, INC ... Praxis Precision Medicines, Inc ... (the "Registrant") to be issued pursuant to the Praxis Precision Medicines, Inc ... Praxis Precision Medicines, Inc.
Edit

Annual Report for Fiscal Year Ending December 31, 2024 (Form 10-K) (Praxis Precision Medicines Inc)

Public Technologies 28 Feb 2025
Overview ... The Independent Data Monitoring Committee, or IDMC, overseeing the interim analysis of Study 1 of the Essential3 program has provided Praxis with the outcome of such analysis ... •further invest in our pipeline; ... Praxis Precision Medicines Inc.
  • 1
×